Legal Negative

Molina Healthcare Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Molina Healthcare, Inc. - MOH

Breaking news from global financial markets

il y a 1 mois
Lire Plus
KBR Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against KBR, Inc. - KBR

KBR Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against KBR, Inc. - KBR

Legal
il y a 1 mois 3,907
Lire Plus
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK

Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK

Legal
il y a 1 mois 4,642
Lire Plus
C3.ai Shareholder Alert: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against C3.ai, Inc. - AI

C3.ai Shareholder Alert: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against C3.ai, Inc. - AI

Legal
il y a 1 mois 4,980
Lire Plus
Dow Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Dow Inc. - DOW

Dow Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Dow Inc. - DOW

Legal
il y a 1 mois 526
Lire Plus
Snap Shareholder Alert: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Snap Inc. - SNAP

Snap Shareholder Alert: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Snap Inc. - SNAP

Legal
il y a 1 mois 2,509
Lire Plus
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering

Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering

IPOs
il y a 1 mois 1,091
Lire Plus
NGG Investor News: If You Have Suffered Losses in National Grid plc (NYSE: NGG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NGG Investor News: If You Have Suffered Losses in National Grid plc (NYSE: NGG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Legal
il y a 1 mois 4,319
Lire Plus
Fossil Announces Convening Hearing for Restructuring Plan

Fossil Announces Convening Hearing for Restructuring Plan

Markets
il y a 1 mois 1,124
Lire Plus
Volcan Compañía Minera S.A.A. Offer to Purchase for Cash Any and All of its Outstanding 8.750% Senior Secured Notes due 2030 and Consent Solicitation

Volcan Compañía Minera S.A.A. Offer to Purchase for Cash Any and All of its Outstanding 8.750% Senior Secured Notes due 2030 and Consent Solicitation

Markets
il y a 1 mois 3,513
Lire Plus
Brookfield Residential 2025 Third Quarter Results Conference Call Notice

Brookfield Residential 2025 Third Quarter Results Conference Call Notice

Earnings
il y a 1 mois 4,081
Lire Plus
Brookfield Residential 2025 Third Quarter Results Conference Call Notice

Brookfield Residential 2025 Third Quarter Results Conference Call Notice

Earnings
il y a 1 mois 1,285
Lire Plus
Voyageur Mineral Explorers Corp. Provides Update on the Company’s Special Meeting

Voyageur Mineral Explorers Corp. Provides Update on the Company’s Special Meeting

Markets
il y a 1 mois 3,069
Lire Plus
University of Phoenix Backers Raise $136 Million in IPO

University of Phoenix Backers Raise $136 Million in IPO

IPOs
il y a 1 mois 2,953
Lire Plus
Nilo Therapeutics เปิดตัวด้วยการระดมทุนรอบ Series A มูลค่าถึง 101 ล้านเหรียญสหรัฐ เพื่อพัฒนายาประเภทใหม่ที่มุ่งเป้าไปที่วงจรระบบประสาทในโรคภูมิคุ้มกัน รวมถึงแต่งตั้ง Kim Seth เป็นประธานเจ้าหน้าที่บริหาร

Nilo Therapeutics เปิดตัวด้วยการระดมทุนรอบ Series A มูลค่าถึง 101 ล้านเหรียญสหรัฐ เพื่อพัฒนายาประเภทใหม่ที่มุ่งเป้าไปที่วงจรระบบประสาทในโรคภูมิคุ้มกัน รวมถึงแต่งตั้ง Kim Seth เป็นประธานเจ้าหน้าที่บริหาร

IPOs
il y a 1 mois 2,912
Lire Plus
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo

Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo

Markets
il y a 1 mois 4,412
Lire Plus
Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO

Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO

Markets
il y a 1 mois 1,570
Lire Plus
Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif

Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif

IPOs
il y a 1 mois 3,600
Lire Plus
니로 테라퓨틱스(Nilo Therapeutics), 면역질환의 신경 회로를 표적으로 하는 신약 계열 개발 추진 목표로 1억 100만 달러 규모의 시리즈 A 투자 유치에 나서며 킴 세스(Kim Seth) 박사를 CEO로 임명

니로 테라퓨틱스(Nilo Therapeutics), 면역질환의 신경 회로를 표적으로 하는 신약 계열 개발 추진 목표로 1억 100만 달러 규모의 시리즈 A 투자 유치에 나서며 킴 세스(Kim Seth) 박사를 CEO로 임명

Markets
il y a 1 mois 2,453
Lire Plus
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任命

ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任命

Markets
il y a 1 mois 2,420
Lire Plus

Tendances Actuelles

1

IO DeFi Launches New Mobile App, Making BTC and XRP Hashrate Earnings Accessible...

28,394 il y a 3 jours
2

BPCE : Mise à disposition du troisième amendement au document d’enregistrement u...

2,280 il y a 3 jours
3

AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit w...

6,648 il y a 3 jours
4

BTCC November 2025 Product Update: Exchange Introduces Futures Pro Copy Trading

45,524 il y a 3 jours
5

Trex Company, Inc. (TREX) Faces Investor Scrutiny Amid Disappointing Q3, Revised...

29,300 il y a 3 jours

Sujets Tendance

Sentiment (24h)

Positif
0
Neutre
0
Négatif
0